New Delhi, 8 Aug 2024: In a decision that would make drugs manufactured outside India more accessible and affordable in the local market the Central government has decided to waive the requirement for clinical trials in India if the drugs are approved in the United States, United......
View Details

Related News

• Big revelation in death of four pregnant women in Damoh Hospital (19-10-2024)

---

• Gujarat FDCA rolls out training for 150 officers on Revised Schedule M Guidelines (19-10-2024)

---

• Meghalaya BSF intercepts Phensedyl smuggling attempt (19-10-2024)

---

• One smuggler arrested with 188 injections (19-10-2024)

---

• Bulk drugs and drug intermediates import decline 13.2% in H1 FY25 (19-10-2024)

---

• Torrent Pharma fined Rs 6.32 Lakh by NPPA for Price Violation (19-10-2024)

---

• PIL filed on Illegal Import of Refurbished Medical Devices (18-10-2024)

---

• Medical store opening made easy in UP (18-10-2024)

---

• Large quantity of Pregabalin seized in Ajnala (18-10-2024)

---

• DoP asks NPPA to recalculate ceiling price of vitamin product Thiamin 100 mg (18-10-2024)

---